Characteristics of the drugs used to treat multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis
| Drug | Characteristics | ||
| Bactericidal | Sterilising | Resistance prevention | |
| Fluoroquinolones (moxifloxacin/gatifloxacin) | +++ | +++ | +++ |
| Bedaquiline | +++ | +++# | +++ |
| Delamanid | +++ | +++# | +++ |
| Injectables (kanamycin, amikacin, capreomycin) | +++ | + | +++ |
| Linezolid | +++ | +++# | +++ |
| High dose isoniazid | +/++/+++ | + | +++ |
| Carbapenems (imipenem/meropenem) | +++# | # | +++# |
| Clofazimine | +/++ | +++ | +++ |
| Pyrazinamide | + | +++ | + |
| Prothionamide/ethionamide | +/++ | +# | +++ |
| Cycloserine | + | +# | +++ |
| Para-aminosalicylic acid | + | +# | +++ |
#: not fully determined/further evidence needed.